ACTIVE

GELBOPHARMA

Export PDF

Financial year 2024 · closed on 31/12/2024

Net result

-50,1 k €

-135.9% YoY

Revenue

749 k €

-0.2% YoY

Equity

167,4 k €

-23.1% YoY

What does GELBOPHARMA do?

GELBOPHARMA is a Private limited company incorporated in 2004. Its main activity is: Wholesale of fruit and vegetables. Its registered office is in Wavre.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0870.583.413

Incorporation

15/12/2004

Legal form

Private limited company

Registered office

Avenue Edison 19 box D
1300 Wavre · WallonieSee on map

Contributed capital

32 600,00 €

Latest accounts

31/12/2024

Activities (NACE)

46319Wholesale of fruit and vegetables· main 46319Wholesale of fruit and vegetables 46389Wholesale of other food, including fish, crustaceans and molluscs 46389Wholesale of other food, including fish, crustaceans and molluscs 51384Air transport 96040Physical well-being activities+1

Joint committees (2)

Contacts

2 public details availableLog in to view

Signals

Solid equityLow riskGood liquidityHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Revenue	749 k €	-0.2%	750,8 k €	-7.6%	812,4 k €	-6.6%	869,9 k €	-12.8%	997,1 k €	+13.8%	876,3 k €	-2.3%	896,6 k €	+1.7%	881,2 k €	+1.8%	865,8 k €	-3.5%	897 k €		–		902,8 k €	+7.3%	841,7 k €	+7.6%	782,3 k €	+8.6%	720 k €	+12.8%	638,5 k €	+14.8%	556 k €	+2.4%	543,2 k €	+12.1%	484,6 k €
EBITDA	-6,3 k €	+75.2%	-25,3 k €	-115%	173,1 k €	+699%	21,7 k €	-74.9%	86,2 k €	+104%	42,3 k €	-32.7%	62,9 k €	+63.2%	38,5 k €	+22.6%	31,4 k €	+70.9%	18,4 k €	+200%	-18,3 k €	-237%	13,3 k €	-57.3%	31,3 k €	+57.9%	19,8 k €	-28.7%	27,8 k €	+6.3%	26,2 k €	-6.0%	27,8 k €	-7.0%	29,9 k €	-16.7%	35,9 k €
Operating result	-16,8 k €	+50.2%	-33,8 k €	-121%	163,1 k €	+4351%	3,7 k €	-94.7%	68,6 k €	+207%	22,3 k €	-47.8%	42,7 k €	+150%	17,1 k €	+44.1%	11,9 k €	+3833%	301,9 €	+101%	-33,7 k €	-76026%	-44,3 €	-100%	22,9 k €	+79.8%	12,7 k €	-40.4%	21,3 k €	+134%	9,1 k €	-24.4%	12 k €	-20.6%	15,2 k €	-34.9%	23,3 k €
Net result	-50,1 k €	-136%	139,6 k €	+18.7%	117,6 k €	+1049%	-12,4 k €	-121%	60 k €	+546%	9,3 k €	-73.4%	35 k €	+205%	11,5 k €	+173%	4,2 k €	+159%	-7,2 k €	+82.3%	-40,6 k €	-237%	-12 k €	-177%	15,6 k €	+2142%	696 €	-96.7%	21 k €	+582%	3,1 k €	-47.0%	5,8 k €	-3.8%	6 k €	-49.8%	12 k €
Balance sheet
Equity	167,4 k €	-23.1%	217,5 k €	-22.1%	279,4 k €	+72.7%	161,8 k €	-8.6%	177 k €	+47.7%	119,8 k €	+5.7%	113,4 k €	+39.6%	81,2 k €	+39.0%	58,4 k €	+7.8%	54,2 k €	-11.7%	61,4 k €	-39.8%	101,9 k €	+2.0%	100 k €	+18.5%	84,4 k €	+3.3%	81,7 k €	+34.5%	60,7 k €	+5.3%	57,6 k €	+11.2%	51,8 k €	+16.7%	44,4 k €
Total assets	265,4 k €	-38.4%	431,1 k €	-12.0%	490,1 k €	+18.0%	415,4 k €	-5.2%	438,1 k €	+17.6%	372,4 k €	-3.2%	384,7 k €	+6.1%	362,6 k €	+1.2%	358,3 k €	-7.8%	388,7 k €	+1.0%	384,9 k €	+1.2%	380,3 k €	+62.5%	233,9 k €	-7.6%	253,1 k €	+26.1%	200,7 k €	+21.3%	165,4 k €	+4.5%	158,2 k €	-18.1%	193,2 k €	+26.9%	152,3 k €
Cash	18,2 k €	-49.8%	36,1 k €	+29.0%	28 k €	-62.1%	74 k €	+10.2%	67,1 k €	+65.8%	40,5 k €	-25.1%	54 k €	+61.8%	33,4 k €	+116%	15,5 k €	-47.3%	29,4 k €	+112%	13,8 k €	-63.9%	38,3 k €	-22.5%	49,4 k €	+16.7%	42,3 k €	+87.4%	22,6 k €	+33.7%	16,9 k €	+28.9%	13,1 k €	+23.0%	10,7 k €	-62.0%	28 k €
Debts	98 k €	-54.1%	213,6 k €	+21.8%	175,3 k €	-30.9%	253,6 k €	-2.5%	260,1 k €	+3.8%	250,7 k €	-5.7%	265,8 k €	-4.3%	277,7 k €	-7.4%	299,9 k €	-10.4%	334,5 k €	+3.4%	323,5 k €	+16.2%	278,3 k €	+108%	134 k €	-20.6%	168,7 k €	+41.8%	119 k €	+13.6%	104,7 k €	+4.1%	100,6 k €	-28.9%	141,4 k €	+31.1%	107,9 k €
Other
Workforce	–		–		–		1,3 ETP		–		–		–		–		–		1,0 ETP	0.0%	1,0 ETP	-50.0%	2,0 ETP	+17.6%	1,7 ETP	+41.7%	1,2 ETP		–		–		–		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2024 · 2 active · 5 ended

Active mandates

GUIDO GELOEN

Director

Active

REGINE BOSMAN

Director

Active

Ended mandates

Guido GELOEN

Mandate

Ended

GUIDO GELOEN

Managing director

Ended

GUIDO GELOEN

Manager

Ended

REGINE BOSMAN

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
ALLONA BELGIUM● Active	0823.608.489
LIMACO● Active	0841.955.248
M&M PROJECTS● Active	0806.473.638
RMT&CO● Active	0730.903.512
The Halo Group● Active	1028.088.053

Annual accounts

Full financial information

	2024	2023	2022	2021	2020	2019
Type of account	Micro model	Micro model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	30/09/2025	26/11/2024	27/09/2023	07/11/2022	15/12/2021	10/12/2020
General meeting	30/05/2025	31/05/2024	26/05/2023	27/05/2022	28/05/2021	29/05/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2024	30/05/2025	30/09/2025	French	PDF
Micro model	31/12/2023	31/05/2024	26/11/2024	French	PDF
Abridged model	31/12/2022	26/05/2023	27/09/2023	French	PDF
Abridged model	31/12/2021	27/05/2022	07/11/2022	French	PDF
Abridged model	31/12/2020	28/05/2021	15/12/2021	French	PDF
Abridged model	31/12/2019	29/05/2020	10/12/2020	French	PDF
Abridged model	31/12/2018	31/05/2019	03/12/2019	French	PDF
Abridged model	31/12/2017	25/05/2018	05/12/2018	French	PDF
Abridged model	31/12/2016	26/05/2017	09/10/2017	French	PDF
Abridged model	31/12/2015	27/05/2016	22/08/2016	French	PDF
Abridged model	31/12/2014	29/05/2015	27/08/2015	French	PDF
Abridged model	31/12/2013	30/05/2014	22/08/2014	French	PDF
Abridged model	31/12/2012	31/05/2013	27/08/2013	French	PDF
Abridged model	31/12/2011	25/05/2012	22/08/2012	French	PDF
Abridged model	31/12/2010	27/05/2011	28/09/2011	French	PDF
Abridged model	31/12/2009	28/05/2010	26/08/2010	French	PDF
Abridged model	31/12/2008	29/05/2009	28/08/2009	French	PDF
Abridged model	31/12/2007	30/05/2008	02/07/2008	French	PDF
Abridged model	31/12/2006	24/06/2007	02/07/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 2 active · 5 ended

Active mandates

GUIDO GELOEN

Director

Active

REGINE BOSMAN

Director

Active

Ended mandates

Guido GELOEN

Mandate

Ended

GUIDO GELOEN

Managing director

Ended

GUIDO GELOEN

Manager

Ended

REGINE BOSMAN

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Registered office30/06/2022
SIEGE SOCIAL - ADRESSE AUTRE QUE SIEGE SOCIAL
PDF
Mandates29/05/2019
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - OBJET - DEMISSIONS, NOMINATIONS
PDF
Registered office23/05/2014
SIEGE SOCIAL
PDF
Mandates25/06/2013
CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
PDF
Other27/12/2004
RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2024
Annual accounts 2024-50,1 k €↓
2023
Annual accounts 2023139,6 k €↑
2022
Annual accounts 2022117,6 k €↑
2021
Annual accounts 2021-12,4 k €↓
2020
Annual accounts 202060 k €↑
2019
Annual accounts 20199,3 k €↓
2018
Annual accounts 201835 k €↑
2017
Annual accounts 201711,5 k €↑
2016
Annual accounts 20164,2 k €↑
2015
Annual accounts 2015-7,2 k €↑
2014
Annual accounts 2014-40,6 k €↓
2013
Annual accounts 2013-12 k €↓
2012
Annual accounts 201215,6 k €↑
2011
Annual accounts 2011696 €↓
2010
Annual accounts 201021 k €↑
2009
Annual accounts 20093,1 k €↓
2008
Annual accounts 20085,8 k €↓
2007
Annual accounts 20076 k €↓
2006
Annual accounts 200612 k €
15/12/2004
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

GELBOPHARMA

Overview

What does GELBOPHARMA do?

Trend over 19 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline